The Registry of Toxic Effects of Chemical Substances
Distannoxane, hexabutyl - |
UPDATE: November 2004 | MW: 596.16 | MF: C24H54OSn2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
50 µg/24 hour
|
severe
|
28ZPAK -,232,1972
|
eye | rabbit
100 µL/24 hour
|
mild
|
NTIS** OTS0571281
|
skin | human
0.1%/48 hour
|
severe
|
JIDEAE 12,161,1985
|
skin | rabbit
500 µL/24 hour
|
severe
|
NTIS** OTS0571281
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
5 mg/L
|
MUREAV 188,65,1987
|
DNA damage
|
Bacillus subtilis
|
100 µg/disk
|
MUREAV 280,195,1992
|
DNA damage
|
human
other cell types
|
0.3 nmol/L
|
MAERE* 53,243,2002
|
DNA inhibition
|
other microorganisms
|
56,200 ppb
|
AEMIDF 45,48,1983
|
mutation in microorganisms
|
Salmonella typhimurium
|
10 ng/tube (+enzymatic activation step)
|
MUREAV 300,265,1993
|
mutation in microorganisms
|
Salmonella typhimurium
|
100 µg/L (-enzymatic activation step)
|
MUREAV 188,65,1987
|
micronucleus test
|
oral | mouse
60 mg/kg
|
MUREAV 188,65,1987
|
other mutation test systems
|
hamster
ovary
|
15 µg/L
|
MUREAV 300,5,1993
|
other mutation test systems
|
other microorganisms
|
56,200 ppb
|
AEMIDF 45,48,1983
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 400 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOLED5 50,257,1990
|
oral | mouse
lowest published toxic dose: 50 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetal death
|
TOLED5 50,257,1990
|
oral | mouse
lowest published toxic dose: 324 mg/kg (6-17 day pregnant)
|
Reproductive: Other effects on female | Reproductive: Specific developmental abnormalities: Musculoskeletal system
TJADAB 53,29A,1996
|
oral | mouse
lowest published toxic dose: 324 mg/kg (6-17 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)
CGANE7 37,251,1997
|
oral | rat
lowest published toxic dose: 150 mg/kg (6-20 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death
TXAPA9 97,113,1989
|
oral | rat
lowest published toxic dose: 150 mg/kg (6-20 day pregnant)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) Reproductive: Effects on newborn: Delayed effects
TXAPA9 97,113,1989
|
oral | rat
lowest published toxic dose: 40 mg/kg (5 day after birth)
|
Reproductive: Specific developmental abnormalities: Central nervous system | Reproductive: Effects on newborn: Delayed effects
TXAPA9 97,113,1989
|
oral | rat
lowest published toxic dose: 150 mg/kg (6-20 day pregnant)
|
Reproductive: Effects on newborn: Behavioral
|
TXAPA9 97,113,1989
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 37,100 mg/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Endocrine: Tumors Endocrine: Thyroid tumors
FCTOD7 28,179,1990
|
oral | rat
lowest published toxic dose: 36,500 mg/kg/2 year- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Endocrine: Tumors
NTIS** OTS0571285
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | guinea pig
lowest published lethal concentration: 200 mg/m3
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Aggression Lung, Thorax, or Respiration: Dyspnea
EJTXAZ 9,339,1976
|
intraperitoneal | mouse
lethal dose (50 percent kill): 12,500 µg/kg
|
Nutritional and Gross Metabolic: Body temperature decrease
|
RPTOAN 42,73,1979
|
intraperitoneal | rat
lethal dose (50 percent kill): 5 mg/kg
|
Behavioral: Coma | Gastrointestinal: Alteration in gastric secretion Nutritional and Gross Metabolic: Other changes
NTIS** OTS0571270
|
intravenous | mouse
lethal dose (50 percent kill): 6 mg/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Lung, Thorax, or Respiration: Other changes
EJTXAZ 9,31,1976
|
oral | mouse
lethal dose (50 percent kill): 55 mg/kg
|
N/R
|
GISAAA 41(5),10,1976
|
oral | rat
lethal dose (50 percent kill): 87 mg/kg
|
N/R
|
85JCAE -,1255,1986
|
oral | rabbit
lowest published lethal dose: 50 mg/kg
|
N/R
|
SAIGBL 15,3,1973
|
skin | mouse
lethal dose (50 percent kill): 163 mg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Behavioral: Change in motor activity (specific assay) Kidney, Ureter, and Bladder: Other changes
SRTCAC 36(1-4),10,1989
|
skin | rat
lethal dose (50 percent kill): >300 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Skin: After systemic exposure: Dermatitis, other
NTIS** OTS0571915
|
skin | rabbit
lethal dose (50 percent kill): 900 mg/kg
|
Behavioral: Somnolence (general depressed activity) | Lung, Thorax, or Respiration: Acute pulmonary edema Gastrointestinal: Hypermotility, diarrhea
EJTXAZ 9,31,1976
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 2,800 µg/m3/4 hour/32 day- intermittent
|
Behavioral: Food intake (animal) | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTIS** OTS0571293
|
oral | monkey
lowest published toxic dose: 21,120 µg/kg/22 week- intermittent
|
Blood: Changes in leukocyte (WBC) count
|
FCTOD7 30,715,1992
|
oral | mouse
lowest published toxic dose: 1,860 mg/kg/4 day- continuous
|
Endocrine: Changes in spleen weight | Blood: Changes in leukocyte (WBC) count Nutritional and Gross Metabolic: Weight loss or decreased weight gain
PCBPBS 6,270,1976
|
oral | rat
lowest published toxic dose: 3,360 mg/kg/6 week- continuous
|
Endocrine: Changes in thymus weight | Blood: Changes in spleen Immunological Including Allergic: Decreased immune response
TXAPA9 148,126,1998
|
oral | rat
lowest published toxic dose: 390 mg/kg/26 week- intermittent
|
Endocrine: Other changes | Endocrine: Changes in pituitary weight Endocrine: Changes in thymus weight
APJAAG 30,955,1980
|
oral | rat
lowest published toxic dose: 462 mg/kg/22 week- continuous
|
Endocrine: Changes in thymus weight | Immunological Including Allergic: Decreased immune response
TXAPA9 105,144,1990
|
oral | rat
lowest published toxic dose: 1,400 mg/kg/28 day- continuous
|
Endocrine: Other changes | Endocrine: Changes in spleen weight
JTEHD6 32,307,1991
|
oral | rat
lowest published toxic dose: 1,700 mg/kg/34 day- continuous
|
Immunological Including Allergic: Decreased immune response
|
JTEHD6 32,307,1991
|
oral | rat
lowest published toxic dose: 2,240 mg/kg/4 week- continuous
|
Endocrine: Changes in thymus weight | Blood: Changes in spleen Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 8,960 mg/kg/4 week- continuous
|
Brain and Coverings: Changes in brain weight | Kidney, Ureter, and Bladder: Changes in kidney weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 140 mg/kg/4 week- continuous
|
Blood: Eosinophilia
|
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 2,240 mg/kg/4 week- continuous
|
Blood: Luekopenia | Blood: Changes in spleen
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 140 mg/kg/4 week- continuous
|
Liver: Changes in liver weight | Blood: Other changes
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 8.4 mg/kg/4 week- continuous
|
Blood: Changes in spleen
|
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 33.6 mg/kg/4 week- continuous
|
Skin and Appendages: Other: Hair | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 134.4 mg/kg/4 week- continuous
|
Behavioral: Somnolence (general depressed activity) | Blood: Changes in cell count (unspecified) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 537.6 mg/kg/4 week- continuous
|
Behavioral: Muscle weakness | Behavioral: Ataxia Liver: Hepatitis (hepatocellular necrosis), diffuse
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 7 mg/kg/4 week- continuous
|
Liver: Changes in liver weight | Blood: Changes in spleen
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 28 mg/kg/4 week- continuous
|
Skin and Appendages: Other: Hair
|
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 112 mg/kg/4 week- continuous
|
Behavioral: Somnolence (general depressed activity) | Endocrine: Changes in thymus weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 448 mg/kg/4 week- continuous
|
Behavioral: Ataxia | Blood: Changes in cell count (unspecified) Nutritional and Gross Metabolic: Weight loss or decreased weight gain
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 252 mg/kg/6 week- continuous
|
Endocrine: Other changes
|
TXAPA9 75,363,1984
|
oral | rat
lowest published toxic dose: 1,008 mg/kg/6 week- continuous
|
Endocrine: Evidence of thyroid hypofunction | Endocrine: Change in LH
TXAPA9 75,363,1984
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 0.1 mg(Sn)/m3;short term exposure limit 0.2 mg/m3 (skin)
|
DTLVS* TLV/BEI,1999
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Not classifiable as a human carcinogen
|
DTLVS* TLV/BEI,1999
|
TOXICOLOGY REVIEW
|
|
TOLED5 127,135,2002
|
TOXICOLOGY REVIEW
|
|
EQSFAP 4,80,1975
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988
|
PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION
|
FEREAC 54,7740,1989
|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF
|
PESTICIDES: Supported
|
RBREV* -,207,1998
|
Mine Safety and Health Administration (MSHA) STANDARD - air
|
time-weighted average 0.1 mg(Sn)/m3
|
DTLVS* 3,258,1971
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry)
|
8 hour time-weighted average 0.1 mg(Sn)/m3
|
CFRGBR 29,1910.1000,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction)
|
8 hour time-weighted average 0.1 mg(Sn)/m3
|
CFRGBR 29,1926.55,1994
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards)
|
8 hour time-weighted average 0.1 mg(Sn)/m3
|
CFRGBR 29,1915.1000,1993
|
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors)
|
8 hour time-weighted average 0.1 mg(Sn)/m3
|
CFRGBR 41,50-204.50,1994
|
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 0.1 mg(Sn)/m3, Skin, JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 0.002 ppm (0.05 mg/m3), Skin, JAN1999
|
Occupational Exposure Limit - AUSTRIA
|
MAK 0.1 mg(Sn)/m3, Skin, JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 0.1 mg(Sn)/m3, Skin, JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.1 mg(Sn)/m3, Skin, JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 0.1 mg(Sn)/m3, short term exposure limit 0.3 mg(Sn)/m3, Skin, JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 0.1 mg(Sn)/m3, short term exposure limit 0.2 mg(Sn)/m3, JAN1993
|
Occupational Exposure Limit - GERMANY
|
MAK 0.002 ppm (0.05 mg/m3), JAN1993
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 0.05 mg/m3, 2003
|
Occupational Exposure Limit - HUNGARY
|
short term exposure limit 0.1 mg(Sn)/m3, Skin, JAN1993
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 0.1 mg(Sn)/m3, JAN1999
|
Occupational Exposure Limit - THE PHILIPPINES
|
time-weighted average 0.1 mg(Sn)/m3, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
NGV 0.1 mg(Sn)/m3, KTV 0.2 mg(Sn)/m3, Skin, JAN1999
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 0.002 ppm (0.05 mg(Sn)/m3), KZG- week 0.01 ppm, Skin, JAN1999
|
Occupational Exposure Limit - THAILAND
|
time-weighted average 0.1 mg(Sn)/m3, JAN1993
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 0.1 mg(Sn)/m3, short term exposure limit 0.2 mg(Sn)/m3, Skin, SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Not classifiable as a human carcinogen
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Not classifiable as a human carcinogen |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ORGANOTIN COMPOUND-air
|
10 hour time-weighted average 0.1 mg(Sn)/m3
|
NIOSH* DHHS #92-100,1992
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 84318; | Number of Industries 25; Total Number of Facilities 1,217; Number of Occupations 24; Total Number of Employees Exposed 7,773
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 84318; |
Number of Industries 45; Total Number of Facilities 2,686; Number of Occupations 31; Total Number of Employees Exposed 36,413; Total Number of Female Employees Exposed 7,903 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a biocide in paint and wood preservatives
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
|
REFERENCES:
CODEN
|
|
REFERENCE
28ZPAK
|
"Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro
Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972
|
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
AEMIDF
|
Applied and Environmental Microbiology. (American Soc. for Microbiology, 1913 I St., NW,
Washington, DC 20006) V.31- 1976-
|
APJAAG
|
Acta Pathologica Japonica. (Japan Publications Trading Co., Ltd., POB 5030, Tokyo
International, Tokyo 101-31, Japan) V.1- 1951-
|
CFRGBR
|
Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents,
Washington, DC 20402)
|
CGANE7
|
Congenital Anomalies. (Nippon Senten Ijo Gakkai, 377-2 Ono-higashi, Osakasayama, Osaka-Fu 589
Japan) V.27- 1987-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EJTXAZ
|
European Journal of Toxicology and Environmental Hygiene. (Paris, France) V.7-9, 1974-76.
For publisher information, see TOERD9.
|
EQSFAP
|
Environmental Quality and Safety. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1972-76. Discontinued.
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
JIDEAE
|
Journal of Investigative Dermatology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore,
MD 21202) V.1- 1938-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MAERE*
|
Marine Environmental Research. (Kidlington, Oxford : Elsevier) V. 1- 1978-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
PCBPBS
|
Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1971-
|
RBREV*
|
Status of Pesticides in Registration, Reregistration, and Special Review (Rainbow Report),
Special Review and Reregistration Division Office of Pesticide Programs U.S. Environmental
Protection Agency, 401 M. Street, S.W., Washington, D.C. 20460, Spring 1998
|
RPTOAN
|
Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed
Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967-
|
SAIGBL
|
Sangyo Igaku. Japanese Journal of Industrial Health. (Nippon Sangyo Eisei Igakkai, Kosu
Eisei Bldg., 1-29-8, Shinjuku, Shinjuku-ku, Tokyo 160, Japan) V.1- 1959-
|
SRTCAC
|
Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. (Tohoku
University, Research Institute for Tuberculosis and Cancer, 4-1 Seiryo-machi, Sendai, Japan)
V.1- 1949-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
|